Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.925
+0.065 (3.49%)
Nov 5, 2024, 1:14 PM EST - Market open

Immuneering Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
55215128426--
Market Cap Growth
-87.20%67.99%-69.91%---
Enterprise Value
-012216267--
Last Close Price
1.867.354.8516.17--
PE Ratio
--3.91-2.53-6.56--
PS Ratio
--404.05204.62--
PB Ratio
0.832.381.172.73--
P/FCF Ratio
-0.74-4.36-2.86-13.77--
P/OCF Ratio
-0.75-4.39-2.90-13.80--
EV/Sales Ratio
--49.59128.17--
EV/EBITDA Ratio
0.48-2.11-0.31-7.88--
EV/EBIT Ratio
0.48-2.10-0.30-7.87--
EV/FCF Ratio
0.57-2.48-0.35-8.62--
Debt / Equity Ratio
0.070.050.040.030.020.35
Debt / FCF Ratio
-0.08-0.09-0.11-0.17-0.04-0.79
Asset Turnover
--0.000.020.09-
Quick Ratio
8.8110.9213.1026.5316.6627.69
Current Ratio
9.3911.3513.5027.0416.7327.83
Return on Equity (ROE)
-61.81%-53.36%-38.00%-35.01%-74.56%-
Return on Assets (ROA)
-37.42%-32.46%-22.38%-20.65%-40.66%-
Return on Capital (ROIC)
-39.70%-34.81%-23.43%-21.44%-42.85%-
Earnings Yield
-101.65%-24.86%-39.44%-7.88%--
FCF Yield
-92.68%-22.92%-35.02%-7.26%--
Buyback Yield / Dilution
-8.98%-7.69%-93.84%-175.00%0.00%-
Total Shareholder Return
-8.98%-7.69%-93.84%-175.00%0.00%-
Source: S&P Capital IQ. Standard template. Financial Sources.